Sedation and Analgesia

Pediatric Critical Care

Volumn , Issue , 2006, Pages 1748-1779

  Heard, Christopher ^a   Fletcher, James E ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67650164160     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032301808-1.50119-X     Document Type: Chapter

References (169)

1. Rundshagen I, Schnabel K, Wegner C, et al. Incidence of recall, nightmares, and hallucinations during analgosedation in intensive care. Intensive Care Med 2002, 28:38-43.
2. Wagner BK, Zavotsky KE, Sweeney JB, et al. Patient recall of therapeutic paralysis in a surgical critical care unit. Pharmacotherapy 1998, 18:358-363.
3. Jones C, Griffiths RD, Humphris G, et al. Memory, delusions, and the development of acute posttraumatic stress disorder-related symptoms after intensive care. Crit Care Med 2001, 29:573-580.
4. Playfor S, Thomas D, Choonara I Recollection of children following intensive care. Arch Dis Child 2000, 83:445-448.
5. Ramsay MA, Savege TM, Simpson BR, et al. Controlled sedation with aphaxalone-alphadone. Br Med J 1974, 2:656-659.
6. Brattebø G, Hofoss D, Flaatten H, et al. Effect of scoring system and protocol for sedation on duration of patients' need for ventilator support in a surgical intensive care unit. BMJ 2002, 324:1386-1389.
7. Ambuel B, Hamlett KW, Marx CM, et al. Assessing distress in pediatric intensive care environments: the COMFORT scale. J Pediatr Psychol 1992, 17:95-109.
8. Detriche O, Berre J, Massaut J, et al. The Brussels sedation scale: use of a simple clinical sedation scale can avoid excessive sedation in patients undergoing mechanical ventilation in the intensive care unit. Br J Anaesth 1999, 83:698-701.
9. Sebel PS, Lang E, Rampil IJ, et al. A multicenter study of bispectral electroencephalogram analysis for monitoring anesthetic effects. Anesth Analg 1997, 84:891-899.
10. Berkenbosch JW, Fichter CR, Tobias JD The correlation of the bispectral index monitor with clinical sedation scores during mechanical ventilation in the pediatric intensive care unit. Anesth Analg 2002, 94:506-511.
11. Rosow C, Manberg PJ Bispectral index monitoring. Anesthesiol Clin North America 1998, 2:89-107.
12. Struys M, Versichelen L, Byttebier G, et al. Clinical usefulness of the bispectral index for titrating target effect-site concentration. Anesthesia 1998, 53:4-12.
13. Courtman SP, Wardurgh A, Petros AJ Comparison of the bispectral index monitor with the comfort score in assessing level of sedation of critically ill children. Intensive Care Med 2003, 29:2239-2246.
14. Moerman N, Bonke B, Oosting J Awareness and recall during general anesthesia. Anesthesiology 1993, 79:454-464.
15. Domino KB, Posner KL, Caplan RA, et al. Awareness during anesthesia. A closed claims analysis. Anesthesiology 1999, 90:1053-1061.
16. Aneja R, Heard AM, Fletcher JE, et al. Sedation monitoring of children by the Bispectral Index in the pediatric intensive care unit. Pediatr Crit Care Med 2003, 4:60-64.
17. Zhou L, Zhang Q, Stein C, et al. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 1998, 286:1000-1006.
18. Kalso E, Tramer MR, Carroll D, et al. Pain relief from intra-articular morphine after knee surgery: a qualitative systematic review. Pain 1997, 71:127-134.
19. Zadina JE, Martin-Schild S, Gerall AA, et al. Endomorphins: novel endogenous mu-opiate receptor agonists in regions of high mu-opiate receptor density. Ann N Y Acad Sci 1999, 897:136-144.
20. Slappendel R, Weber EW, Benraad B, et al. Itching after intrathecal morphine. Incidence and treatment. Eur J Anaesthesiol 2000, 17:616-621.
21. Sabbe MB, Yaksh TL Pharmacology of spinal opioids. J Pain Symptom Manage 1990, 5:191-203.
22. Kart T, Christrup LL, Rasmussen M Recommended use of morphine in neonates, infants and children based on a literature review: Part 1 Pharmacokinetics. Paediatr Anaesth 1997, 7:5-11.
23. Smith GD, Smith MT Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat. Pain 1995, 62:51-60.
24. Williams PI, Sarginson RE, Ratcliffe JM Use of methadone in the morphine-tolerant burned paediatric patient. Br J Anaesth 1998, 80:92-95.
25. Laulin JP, Maurette P, Corcuff JB, et al. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg 2002, 94:1263-1269.
26. Latta KS, Ginsberg B, Barkin RL Meperidine: a critical review. Am J Ther 2002, 9:53-68.
27. Kavuri S, Robalino J, Janardhan Y, et al. Low-dose intrathecal meperidine for lower limb orthopaedic surgery. Can J Anaesth 1990, 37:947-948.
28. Sharar SR, Bratton SL, Carrougher GJ, et al. A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia. J Burn Care Rehabil 1998, 19:521.
29. McEwan A, Sigston PE, Andrews KA, et al. A comparison of rectal and intramuscular codeine phosphate in children following neurosurgery. Paediatr Anaesth 2000, 10:189-193.
30. Goldsack C, Scuplak SM, Smith M A double-blind comparison of codeine and morphine for postoperative analgesia following intracranial surgery. Anaesthesia 1996, 51:1029-1032.
31. Paris A, Scholz J, von Knobelsdorff G, et al. The effect of remifentanil on cerebral blood flow velocity. Anesth Analg 1998, 87:569-573.
32. Paris A, Scholz J, von Knobelsdorff G, et al. The effect of remifentanil on cerebral blood flow velocity. Anesth Analg 1998, 87:569-573.
33. Vinik RH, Kissin I Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 1998, 86:1307-1311.
34. Shipton EA Tramadol present and future. Anaesth Intensive Care 2000, 28:363-374.
35. Rosen DA, Morris JL, Rosen KR, et al. Nalmefene to prevent epidural narcotic side effects in pediatric patients: a pharmacokinetic and safety study. Pharmacotherapy 2000, 20:745-749.
36. Claster S, Vichinsky EP Managing sickle cell disease. BMJ 2003, 327:1151-1155.
37. Ballas SK, Viscusi ER, Epstein KR Management of acute chest wall sickle cell pain with nebulized morphine. Am J Hematol 2004, 76:190-191.
38. Siddappa R, Fletcher JE, Heard AM, et al. Methadone dosage for prevention of opioid withdrawal in children. Paediatr Anaesth 2003, 13:805-810.
39. Katz R, Kelly HW, His A Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med 1994, 22:763-767.
40. Joshi P, et al. Opiate use and tolerance in the PICU. Crit Care Med 2003, A130:S526.
41. Deutsch ES, Nadkarni VM Clonidine prophylaxis for narcotic and sedative withdrawal syndrome following laryngotracheal reconstruction. Arch Otolaryngol Head Neck Surg 1996, 122:1234-1238.
42. Kienbaum P, Scherbaum N, Thurauf N, et al. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns. Crit Care Med 2000, 28:969-976.
43. Pfab R, Hirtl C, Zilker T Opiate detoxification under anesthesia: no apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure. J Toxicol Clin Toxicol 1999, 37:43-50.
44. Stephenson J Experts debate merits of 1-day opiate detoxification under anesthesia. JAMA 1997, 277:363-364.
45. Siddappa S, et al. The use of propofol during rapid opiate weaning in the PICU. Crit Care Med 2002, A183:S606.
46. Sigel E Mapping of the benzodiazepine recognition site on GABA(A) receptors. Curr Top Med Chem 2002, 2:833-839.
47. Ernst M, Brauchart D, Boresch S, et al. Comparative modeling of GABA(A) receptors: limits, insights, future developments. Neuroscience 2003, 119:933-934.
48. Rudolph U Identification of molecular substrate for the attenuation of anxiety: a step toward the development of better anti-anxiety drugs. Sci World J 2001, 1:192-193.
49. Beurdeley-Thomas A, Miccoli L, Oudard S, et al. The peripheral benzodiazepine receptors: a review. J Neurooncol 2000, 46:45-56.
50. Casellas P, Galiegue S, Basile AS Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 2002, 40:475-486.
51. Arvat E, Giordano R, Grottoli S, et al. Benzodiazepines and anterior pituitary function. J Endocrinol Invest 2002, 25:735-747.
52. Kolmer M, Rovio A, Alho H The characterization of two diazepam binding inhibitor (DBI) transcripts in humans. Biochem J 1995, 306(pt 2):327-330.
53. Ohkuma S, Katsura M, Tsujimura A Alterations in cerebral diazepam binding inhibitor expression in drug dependence: a possible biochemical alteration common to drug dependence. Life Sci 2001, 68:1215-1222.
54. Sand P, Kavvadias D, Feineis D, et al. Naturally occurring benzodiazepines: current status of research and clinical implications. Eur Arch Psychiatry Clin Neurosci 2000, 250:194-202.
55. Robin C, Trieger N Paradoxical reactions to benzodiazepines in intravenous sedation: a report of 2 cases and review of the literature. Anesth Prog 2002, 49:128-132.
56. Jacqz-Aigrain E, Burtin P Clinical pharmacokinetics of sedatives in neonates. Clin Pharmacokinet 1996, 31:423-443.
57. Langlois S, Kreeft JH, Chouinard G, et al. Midazolam: kinetics and effects on memory, sensorium, and haemodynamics. Br J Clin Pharmacol 1987, 23:273-278.
58. Saegusa K, Furukawa Y, Ogiwara Y, et al. Pharmacologic basis of responses to midazolam in the isolated, cross-perfused, canine right atrium. Anesth Analg 1987, 66:711-718.
59. Peinemann F, Daldrup T Severe and prolonged sedation in five neonates due to persistence of active diazepam metabolites. Eur J Pediatr 2001, 160:378-381.
60. Lahat E, Goldman M, Barr J, et al. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ 2000, 321:83-86.
61. Cray SH, Dixon JL, Heard CM, et al. Oral midazolam premedication for paediatric day case patients. Paediatr Anaesth 1996, 6:265-270.
62. Blumer JL Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet 1998, 35:37-47.
63. de Wildt SN, de Hoog M, Vinks AA, et al. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients. Crit Care Med 2003, 31:1952-1958.
64. Bauer TM, Ritz R, Haberthur C, et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 1995, 346:145-147.
65. Malacrida R, Fritz ME, Suter PM, et al. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med 1992, 20:1123-1126.
66. Ahonen J, Olkkola KT, Takala A, et al. Interaction between fluconazole and midazolam in intensive care patients. Acta Anaesthesiol Scand 1999, 43:509-514.
67. Kyriakopoulos AA, Greenblatt DJ, Shader RI Clinical pharmacokinetics of lorazepam: a review. J Clin Psychiatry 1978, 39(10 pt 2):16-23.
68. Lee SA, Lee JK, Heo K Coma probably induced by lorazepam-valproate interaction. Seizure 2002, 11:124-125.
69. Tobias JD, Rasmussen GE Pain management and sedation in the pediatric intensive care unit. Pediatr Clin North Am 1994, 41:1269-1292.
70. Hayman M, Seidl EC, Ali M, et al. Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole. Pharmacotherapy 2003, 23:1190-1194.
71. Chicella M, Jansen P, Parthiban A, et al. Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients. Crit Care Med 2002, 30:2752-2756.
72. Parker MG, Fraser GL, Watson DM, et al. Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy. Intensive Care Med 2002, 28:81-84.
73. Shafer A Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 1998, 26:947-956.
74. Bateson AN Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Des 2002, 8:5-21.
75. Weinbroum AA, Szold O, Ogorek D, et al. The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature. Eur J Anaesthesiol 2001, 18:789-797.
76. Mathieu-Nolf M, Babe MA, Coquelle-Couplet V, et al. Flumazenil use in an emergency department: a survey. J Toxicol Clin Toxicol 2001, 39:15-20.
77. Feld LG, Cimino M Pediatric dosing handbook 1997, Lexi-Comp, Hudson, OH.
78. Winkler E, Almog S, Kriger D, et al. Use of flumazenil in the diagnosis and treatment of patients with coma of unknown etiology. Crit Care Med 1993, 21:538-542.
79. Chern CH, Chern TL, Wang LM, et al. Continuous flumazenil infusion in preventing complications arising from severe benzodiazepine intoxication. Am J Emerg Med 1998, 16:238-241.
80. Peters JM, Tolia V, Simpson P, et al. Flumazenil in children after esophagogastroduodenoscopy. Am J Gastroenterol 1999, 94:1857-1861.
81. Girdler NM, Lyne JP, Wallace R, et al. A randomised, controlled trial of cognitive and psychomotor recovery from midazolam sedation following reversal with oral flumazenil. Anaesthesia 2002, 57:868-876.
82. Pershad J, Palmisano P, Nichols M Chloral hydrate: the good and the bad. Pediatr Emerg Care 1999, 15:432-433.
83. Lash LH, Fisher JW, Lipscomb JC, et al. Metabolism of trichloroethylene. Environ Health Perspect 2000, 108:177-200.
84. Salmon AG, Kizer KW, Zeise L, et al. Potential carcinogenicity of chloral hydrate a review. J Toxicol Clin Toxicol 1995, 33:115-121.
85. Hassaballa HA, Balk RA Torsade de pointes associated with the administration of intravenous haloperidol. Am J Ther 2003, 10:58-60.
86. Kao LW, Kirk MA, Evers SJ, et al. Droperidol, QT prolongation, and sudden death: what is the evidence?. Ann Emerg Med 2003, 41:559-560. comment.
87. Reappraisal of lytic cocktail/demerol, phenergan, and thorazine (DPT) for the sedation of children. American Academy of Pediatrics Committee on Drugs. Pediatrics 1995, 95:598-602.
88. Samson-Fang L, Gooch J, Norlin C Intrathecal baclofen withdrawal simulating neuroleptic malignant syndrome in a child with cerebral palsy. Dev Med Child Neurol 2000, 42:561-565.
89. Kao LW, Amin Y, Kirk MA, et al. Intrathecal baclofen withdrawal mimicking sepsis. J Emerg Med 2003, 24:423-427.
90. Greenberg MI, Hendrickson RG Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement. J Toxicol Clin Toxicol 2003, 41:83-85.
91. Gooch JL, Oberg WA, Grams B, et al. Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg 2003, 39:1-6.
92. Reeves RK, Stolp-Smith KA, Christopherson MW Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. Arch Phys Med Rehabil 1998, 79:353-356.
93. Sampathkumar P, Scanlon P, Plevak D Baclofen withdrawal presenting as multiorgan system failure. Anesth Analg 1998, 87:562-563.
94. Food and Drug Administration Safety Information and Adverse Event Reporting Program: 2002 safety alert - Lioresal (baclofen injection), Available at. Accessed June 2004. http://www.fda.gov/medwatch/SAFETY/2002/baclofen.htm.
95. Meythaler JM, Roper JF, Brunner RC Cyproheptadine for intrathecal baclofen withdrawal. Arch Phys Med Rehabil 2003, 84:638-642.
96. Colachis SC, Rea GL Monitoring of creatinine kinase during weaning of intrathecal baclofen and with symptoms of early withdrawal. Am J Phys Med Rehabil 2003, 82:489-492.
97. Rodarte A, Diaz S, Foley J, et al. The pharmacokinetics of dexmedetomidine in post-surgical pediatric intensive care unit patients: a preliminary study. Anesthesiology 2003, 99:A423.
98. De Wolf AM, Fragen RJ, Avram MJ, et al. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg 2001, 93:1205-1209.
99. Baughman VL, Cunningham F, Layden T, et al. Pharmacokinetic/pharmacodynamic effects of dexmedetomidine in patients with hepatic failure. Anesth Analg 2000, 90:S391.
100. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999, 54:1136-1142.
101. Riker RR, Ramsay MAE, Prielipp RC, et al. Long-term dexmedetomidine infusions for ICU sedation: a pilot study. Anesthesiology 2001, 95:A383.
102. Berkenbosch JW, Tobias JD Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med 2003, 4:203-205.
103. Short TG, Chui PT Propofol and midazolam act synergistically in combination. Br J Anaesth 1991, 67:539-545.
104. Chamorro C, de Latorre FJ, Montero A, et al. Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial. Crit Care Med 1996, 24:932-939.
105. Barrientos-Vega R, Mar Sanchez-Soria M, Morales-Garcia C, et al. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 1997, 25:33-39.
106. Brown LA, Levin GM Role of propofol in refractory status epilepticus. Ann Pharmacother 1998, 32:1053-1059.
107. Stecker MM, Kramer TH, Raps EC, et al. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 1998, 39:18-26.
108. Platt M, White DC Calories in sedation. Anaesthesia 1987, 42:322. AN2269.
109. Valente JF, Anderson GL, Branson RD, et al. Disadvantages of prolonged propofol sedation in the critical care unit. Crit Care Med 1994, 22:710-712.
110. Bach A, Geiss HK Propofol and postoperative infections. N Engl J Med 1995, 30:1505-1506.
111. Bennett SN, McNeil MM, Bland LA, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995, 333:147-153.
112. Laxenaire MC, Mata-Bermejo E, Moneret-Vautrin DA, et al. Life-threatening anaphylactoid reactions to propofol (Diprivan). Anesthesiology 1992, 77:275-280.
113. Bodenham A, Culank LS, Park GR Propofol infusion and green urine. Lancet 1987, 2:740. letter.
114. Parke TJ, Stevens JE, Rice AS, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992, 305:613-616.
115. Propofol infusion in children. BMJ 1992, 305:952-953. letters to the editor.
116. Bray RJ Propofol infusion syndrome in children. Paediatr Anaesth 1998, 8:491-499.
117. Pepperman ML, Macrae D A comparison of propofol and other sedative use in paediatric intensive care in the United Kingdom. Paediatr Anaesth 1997, 7:143-153.
118. Cornfield DN, Tegtmeyer K, Nelson MD, et al. Continuous propofol infusion in 142 critically ill children. Pediatrics 2002, 110:1177-1181.
119. Reed MD, Blumer JL Propofol bashing: the time to stop is now!. Crit Care Med 1996, 24:175-176.
120. Felmet K, Nguyen T, Clark RS, et al. The FDA warning against prolonged sedation with propofol in children remains warranted. Pediatrics 2003, 112:1002-1003.
121. Dear health care provider letter, AstraZeneca, Newark, DE, March 26, 2001.
122. Kang TM Propofol infusion syndrome in critically ill patients. Ann Pharmacother 2002, 36:1453-1456.
123. Cray SH, Robinson BH, Cox PN Lactic academia and bradyarrhythmia in a child sedated with propofol. Crit Care Med 1998, 26:2087-2092.
124. Wolf A, Weir P, Segar P, et al. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 2001, 357:606-607.
125. Vasile B, Rasulo F, Candiani A, et al. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003, 29:1417-1425.
126. Wheeler DS, Vaux KK, Ponaman ML, et al. The safe and effective use of propofol sedation in children undergoing diagnostic and therapeutic procedures: experience in a pediatric ICU and a review of the literature. Pediatr Emerg Care 2003, 19:385-392.
127. Hlozki J, Aring C, Gillor A Death after re-exposure to propofol in a 3-year-old child: a case report. Paediatric Anaesth 2004, 14:265-270.
128. Hanna JP, Ramundo ML Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology 1998, 50:301-303.
129. Cannon ML, Glazier SS, Bauman LA Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion. J Neurosurg 1995, 95:1053-1056.
130. Seigler RS, Avant MG, Gwyn DR, et al. A comparison of propofol and ketamine/midazolam for intravenous sedation of children. Pediatr Crit Care Med 2001, 2:20-23.
131. Festa M, Bowra J, Schell D Use of propofol infusion in Australian and New Zealand paediatric intensive care units. Anaesth Intensive Care 2002, 30:786-793.
132. Lowrie L, Weiss AH, Lacombe C The pediatric sedation unit: a mechanism for pediatric sedation. Pediatrics 1998, 102:E30.
133. Friedman AG, Mulhern RK, Fairclough D, et al. Midazolam premedication for pediatric bone marrow aspiration and lumbar puncture. Med Pediatr Oncol 1991, 19:499-504.
134. American Academy of Pediatrics Committee on Drugs Guidelines for monitoring management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics 1992, 89:276-281.
135. Epstein BS The American Society of Anesthesiologist's efforts in developing guidelines for sedation and analgesia for nonanesthesiologists: the 40th Rovenstine Lecture. Anesthesiology 2003, 98:1261-1268.
136. Practice guidelines for sedation and analgesia by non-anesthesiologists American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Anesthesiology 1996, 84:459-471.
137. Dodson BA Interventional neuroradiology and the anesthetic management of patients with arteriovenous malformations. Anesthesia and neurosurgery 1994, Mosby, St. Louis. J.E. Cotrell, D.S. Smith (Eds.).
138. Rheuban KS, Carpenter MA Diagnostic cardiac catheterization, angiography, and interventional catheterization. Pediatric cardiac anesthesia 1993, Appleton & Lange, Norwalk, Conn. C.L. Lake (Ed.).
139. Keeter S, Benator RM, Weinberg SM, et al. Sedation in pediatric CT: national survey of current practice. Radiology 1990, 175:745-752.
140. Joint Commission on Accreditation of Healthcare Organizations Accreditation manual for hospitals 1993, Mosby-Year-book, St Louis.
141. Wilson S A survey of the American Academy of Pediatric Dentistry membership: nitrous oxide and sedation. Pediatr Dent 1996, 18:287-293.
142. Cote CJ, Karl HW, Notterman DA, et al. Adverse sedation events in pediatrics: analysis of medications used for sedation. Pediatrics 2000, 106:633-644.
143. Dreifuss FE, Rosman NP, Cloyd JC, et al. A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med 1998, 338:1869-1875.
144. Holzman RS, Cullen DJ, Eichhorn JH, et al. Guidelines for sedation by nonanesthesiologists during diagnostic and therapeutic procedures. The Risk Management Committee of the Department of Anaesthesia of Harvard Medical School. J Clin Anesth 1994, 6:265-276.
145. Hoffman GM, Nowakowski R, Troshynski TJ, et al. Risk reduction in pediatric procedural sedation by application of an American Academy of Pediatrics/American Society of Anesthesiologists process model. Pediatrics 2002, 109:236-243.
146. Jorgensen NH, Messick JM, Gray J, et al. ASA monitoring standards and magnetic resonance imaging. Anesth Analg 1994, 79:1141-1147.
147. Heard CMB Nuclear magnetic resonance Imaging. Complications in anesthesia 1999, WB Saunders, Philadelphia,. ed 1. J.L. Atlee (Ed.).
148. Menon DK, Peden CJ, Hall AS, et al. Magnetic resonance for the anaesthetist. Part 1: Physical principles, applications, and safety aspects. Anaesthesia 1992, 47:240-255.
149. Peden CJ, Menon DK, Hall AS, et al. Magnetic resonance for the anaesthetist. Part II. Anaesthesia and monitoring in MR units. Anaesthesia 1992, 47:508-516.
150. Roy TM, Pruitt VL, Garner PA, et al. The potential role of anesthesia in status asthmaticus. J Asthma 1992, 29:73-77.
151. Smith JA, Santer LJ Respiratory arrest following intramuscular ketamine injection in a 4-year-old child. Ann Emerg Med 1993, 22:613-615.
152. Kenyon CJ, McNeil LM, Fraser R Comparison of the effects of etomidate, thiopentone and propofol on cortisol synthesis. Br J Anaesth 1985, 57:509-511.
153. Crozier TA, Flamm C, Speer CP, et al. Effects of etomidate on the adrenocortical and metabolic adaptation of the neonate. Br J Anaesth 1993, 70:47-53.
154. Watt I, Ledingham IM Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984, 39:973-978.
155. Clarke JB, Thomas C, Chen M, et al. Halogenated anesthetics form liver adducts and antigens that cross-react with halothane-induced antibodies. Int Arch Allergy Immunol 1995, 108:24-32.
156. Sponheim S, Skraastad O, Helseth E, et al. Effects of 0.5 and 1.0 MAC isoflurane, sevoflurane and desflurane on intracranial and cerebral perfusion pressures in children. Acta Anaesthesiol Scand 2003, 47:932-938.
157. Petersen KD, Landsfeldt U, Cold GE, et al. Intracranial pressure and cerebral hemodynamic in patients with cerebral tumors: a randomized prospective study of patients subjected to craniotomy in propofol-fentanyl, isoflurane-fentanyl, or sevoflurane-fentanyl anesthesia. Anesthesiology 2003, 98:329-336.
158. Fraga M, Rama-Maceiras P, Rodino S, et al. The effects of isoflurane and desflurane on intracranial pressure, cerebral perfusion pressure, and cerebral arteriovenous oxygen content difference in normocapnic patients with supratentorial brain tumors. Anesthesiology 2003, 98:1085-1090.
159. Tanigami H, Yahagi N, Kumon K, et al. Long-term sedation with isoflurane in postoperative intensive care in cardiac surgery. Artif Organs 1997, 21:21-23.
160. Arnold JH, Truog RD, Rice SA Prolonged administration of isoflurane to pediatric patients during mechanical ventilation. Anesth Analg 1993, 76:520-526.
161. Fujino Y, Nishimura M, Nishimura S, et al. Prolonged administration of isoflurane to patients with severe renal dysfunction. Anesth Analg 1998, 86:440-441.
162. Johnston RG, Noseworthy TW, Friesen EG, et al. Isoflurane therapy for status asthmaticus in children and adults. Chest 1990, 97:698-701.
163. U.S. Department of Labor Occupational Safety and Health Administration: Waste anesthetic gases. OSHA Fact Sheet 91-38, Washington, DC, 1991.
164. U.S. Department of Labor Occupational Safety and Health Administration: Waste anesthetic gases. Available at. Accessed June 2004. http://www.osha.gov/SLTC/wasteanestheticgases.
165. Curley MA, Molengraft JA Providing comfort to critically ill pediatric patients. Crit Care Nurs Clin North Am 1995, 2:267-274.
166. Parnass SM, Feld JM, Chamberlin WH, et al. Status asthmaticus treated with isoflurane and enflurane. Anesth Analg 1987, 66:193-195.
167. Willatts SM, Spencer EM Sedation for ventilation in the critically ill. Anaesthesia 1994, 49:422-428.
168. Kong KL, Willatts SM Isoflurane sedation in pediatric intensive care. Crit Care Med 1995, 23:1308-1309.
169. Wheeler DS, Clapp CR, Ponaman ML, et al. Isoflurane therapy for status asthmaticus in children: a case series and protocol. Pediatr Crit Care Med 2000, 1:55-59.